3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
3
Sarcoma
1
Lymphoid
1
Conditions
Lymphoma, Large B-Cell, Diffuse
97
Leukemia, Lymphocytic, Chronic, B-Cell
88
Lymphoma, Follicular
81
Lymphoma
62
Lymphoma, Mantle-Cell
59
Lymphoma, B-Cell, Marginal Zone
47
Lymphoma, Non-Hodgkin
46
Recurrence
35
Lymphoma, B-Cell
24
Leukemia
20
Waldenstrom Macroglobulinemia
18
Hodgkin Disease
18
Lymphoma, T-Cell, Peripheral
16
Burkitt Lymphoma
14
Lymphoma, T-Cell, Cutaneous
12
Lymphoma, T-Cell
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Sezary Syndrome
10
Mycosis Fungoides
10
Multiple Myeloma
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Lymphoma, Large-Cell, Anaplastic
9
Immunoblastic Lymphadenopathy
8
Lymphoma, Large-Cell, Immunoblastic
7
Intraocular Lymphoma
7
Neoplasms
6
Lymphoma, Extranodal NK-T-Cell
6
Leukemia, B-Cell
6
Leukemia, Hairy Cell
5
Leukemia-Lymphoma, Adult T-Cell
4
Interventions
Temozolomide
9
Filgrastim
7
Specimen Handling
6
X-Rays
5
Rituximab
5
Radiotherapy
5
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
5
Psychiatric Rehabilitation
4
Nuclear Medicine Department, Hospital
4
Methotrexate
4
Etoposide
4
Cyclophosphamide
4
Biopsy
4
etoposide phosphate
3
Pemetrexed
3
Melphalan
3
Cytarabine
3
Carboplatin
3
tazemetostat
2
sargramostim
2
olaparib
2
larotrectinib
2
erdafitinib
2
ensartinib
2
Vincristine
2
Vemurafenib
2
Topotecan
2
Thiotepa
2
Peripheral Blood Stem Cell Transplantation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Lenalidomide
×
Lymphoid
×
Clear all
NCT04446962
2025-09-25
LOC-R01
Institut Curie
Phase 1/2
Active not recruiting
118 enrolled